Ahmad Sulaiman

Summary

Affiliation: University of Malaya
Country: Malaysia

Publications

  1. pmc Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
    Ah Young Lim
    Department of Psychiatry, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea
    BMC Psychiatry 14:37. 2014
  2. ncbi request reprint The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia
    Ahmad Hatim Sulaiman
    Department of Psychological Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia Electronic address
    Compr Psychiatry 55:S89-94. 2014
  3. ncbi request reprint Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
    Mas Ayu Said
    Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Singapore Med J 53:801-7. 2012
  4. pmc A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
    Danielle Coppola
    Janssen Research and Development, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 12:26. 2012
  5. ncbi request reprint Safety and efficacy of rapid dose administration of quetiapine in bipolar mania
    A Hatim
    Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Hum Psychopharmacol 21:313-8. 2006

Collaborators

  • Ah Young Lim
  • Mas Ayu Said
  • Danielle Coppola
  • A Hatim
  • Dianne Bautista
  • Shen Ing Liu
  • Si Tian-Mei
  • Jin Pyo Hong
  • Ahmad Hatim
  • Edwin Chan
  • Ah Rong Lee
  • Chia Yih Liu
  • Pichet Udomratn
  • Hong Jin Jeon
  • Hong Choon Chua
  • Abdul Kadir Abu Bakar
  • Mahesh N Samtani
  • Rosliwati Md Yusoff
  • Srihari Gopal
  • Tsui Huei Loo
  • Isaac Nuamah
  • Mohd Hussain Habil
  • Yanning Liu
  • Gahan Pandina
  • Srijit Das
  • David W Hough
  • Bart Remmerie
  • Shamshunnisah Abu Bakar
  • J Joseph
  • S G Jesjeet
  • S T Jambunathan
  • C C Low
  • H Habil
  • N Z Zuraida

Detail Information

Publications5

  1. pmc Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
    Ah Young Lim
    Department of Psychiatry, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea
    BMC Psychiatry 14:37. 2014
    ..The aim of this study was to evaluate the factors associated with suicidality in patients with major depressive disorder (MDD) from six Asian countries...
  2. ncbi request reprint The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia
    Ahmad Hatim Sulaiman
    Department of Psychological Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia Electronic address
    Compr Psychiatry 55:S89-94. 2014
    ..The association between psychiatric co-morbidity and methamphetamine-induced psychosis was also studied...
  3. ncbi request reprint Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
    Mas Ayu Said
    Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Singapore Med J 53:801-7. 2012
    ..This study aimed to determine the prevalence of metabolic syndrome and risk of coronary heart disease (CHD) in patients with schizophrenia receiving antipsychotics in Malaysia...
  4. pmc A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
    Danielle Coppola
    Janssen Research and Development, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 12:26. 2012
    ..This study evaluates safety and tolerability, as well as pharmacokinetics, of the highest marketed dose of PP (150 mg eq. [234 mg]) in stable patients with schizophrenia over a 1-year period...
  5. ncbi request reprint Safety and efficacy of rapid dose administration of quetiapine in bipolar mania
    A Hatim
    Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Hum Psychopharmacol 21:313-8. 2006
    ..Most patients tolerated rapid titration of quetiapine to 800 mg/day by day 4 of therapy, with a significant improvement in manic symptoms by day 7 of treatment...